این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
یکشنبه 23 آذر 1404
Iranian Heart Journal
، جلد ۱۶، شماره ۱، صفحات ۲۰-۲۵
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
ERUM MYELOPEROXIDASE LEVEL IN PATIENTS WITH CHRONIC HEART FAILURE
چکیده انگلیسی مقاله
ackground: Evidence suggests that the serum myeloperoxidase level has a diagnostic and predictive role in patients with chronic heart failure (CHF). We evaluated the association between the serum myeloperoxidase level and the severity and prognosis of CHF.Patients and Methods: In a prospective observational study, patients with CHF were evaluated. The myeloperoxidase serum level was measured at baseline by enzyme-linked immunosorbent assay. Transthoracic echocardiography was done at baseline and then after 6 months. History and duration of admission and also mortality were recorded during follow-up.Results: Fifty patients at a mean age of 64.7±1.8 years (70% male) were evaluated. The mean serum myeloperoxidase level was 51.0±6.5mg/dL. Accordingly, the patients were classified into two groups of A and B with a serum myeloperoxidase level of less and more than 51mg/dl, respectively. No differences were found between the two groups in New York Heart Association functional class (NYHA III 20.5% vs.27.3%; p value=0.456), left ventricular ejection fraction (30.3±10.0 vs.29.8±10.1%; p value=0.873), systolic dysfunction (48.7% vs.54.5%; p value=0.500), or diastolic dysfunction (38.5% vs.63.6%; p value=0.127) neither at baseline, nor at 6 months' follow-up. The serum myeloperoxidase level was not associated with admission history or mortality.Conclusion: We found no significant association between the serum myeloperoxidase level and echocardiography parameters, admission history, or mortality in patients with CHF. Further studies with larger samples of patients are required in this regard.
کلیدواژههای انگلیسی مقاله
CHRONIC HEART FAILURE, MYELOPEROXIDASE, OUTCOME
نویسندگان مقاله
Mohammad Garakyaraghi |
Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
Mahshid Givi |
Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
Masoumeh Sadeghi |
Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
Ali Pourmoghaddas |
Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
Nehzat Alizadeh |
Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
نشانی اینترنتی
http://journal.iha.org.ir/article_83183_2ad8480b75c61e6c9d79526b05aaf328.pdf
فایل مقاله
اشکال در دسترسی به فایل - ./files/site1/rds_journals/162/article-162-1423962.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات